The presence of left ventricular hypertrophy (LVH) is a potential biomarker for cerebral atrophy in patients with type 2 diabetes, Australian researchers have shown. Dr Sheila Patel, from the vascular neurodegeneration research lab at the Florey Institute, presented preliminary results from the Diabetes and Dementia (D2) study at the Australasian Diabetes Congress (ADC) 2021. The ...
Two risk factors highlighted for cerebral atrophy in T2D
By Mardi Chapman
18 Aug 2021